Shaping the future of the ingredient industry with Naturex

03/09/2016

A map of tomorrow’s ingredient landscape with Naturex’s Open Innovation Commitments

 

Avignon, 9 March 2016 - How are new technologies likely to change the ingredient supply chain? Will industry be able to keep up? In this climate of constant change, collaboration and open-mindedness are essential. Naturex understands that solving the industry’s challenges through disruptive technologies requires involving other parties, wherever they may be.

Open Innovation is key to success

Innovation has always been strongly rooted in Naturex’s DNA. The company’s R&D department has developed long-standing relationships with academic and scientific authorities, leading to successful launches like the recent Eutectys™ cosmetic collection. Another important aspect is licensing. For instance, Naturex recently signed a licensing agreement with Barry Callebaut for marketing cocoa extracts. This agreement with a worldwide player allows Naturex to bring the benefits of cocoa flavanols to the dietary supplement market.

Looking to the future: INGENIUM, an Open Innovation Program

Naturex is launching INGENIUM, an Open Innovation Initiative with the goal of advancing technological breakthroughs by sourcing and supporting innovative ideas from various sources. As part of this program, Naturex will be partnering with new start-up companies whose promising business ideas and technologies may be valuable to the company’s development. Partnerships will include extensive advice and mentoring on various levels, (regulatory, legal, logistics, marketing etc.) and Naturex will also make the company’s facilities - for example the analytical or application labs- available to the chosen candidates.

Naturex is also planning to establish a Technology Advisory Group (TAG) which will include highly respected technology business actors and/or key academic opinion leaders. Privileged research areas shall include biotechnologies, new extraction and cultivation processes, identification of new botanicals or digital marketing technologies.

Doug Klaiber, CEO of Naturex-DBS division, has been asked to set up this Open Innovation Initiative. Doug’s background as an entrepreneur in innovative ingredients at Decas Botanical Synergies (DBS), a company acquired by Naturex in 2012, make him the ideal candidate for this mission.

Olivier Rigaud, CEO of NATUREX, commented: “Open Innovation is key to our BRIGHT2020 strategic plan. Our aim is to generate 10% sales through new product developments by 2020, and we know that innovation cannot be provided solely by our own research.  By crowdsourcing innovation, Naturex can improve customer value, drive advancements across industries and, last but not least, foster local economic development.  We are very proud to be shaping the future of the ingredients industry.”

 

 

 

 

 

About Naturex:

Naturex is the global leader in specialty plant-based natural ingredients. Through its dedicated business units, the Group addresses the specific needs of three strategic markets: Food & Beverages, Nutrition & Health, and Personal Care. The company offers its customers a full array of high-quality ingredients, responsibly sourced from nature for food, nutraceutical and cosmetic applications.

Naturex’s head office is in Avignon, France. The company employs more than 1,700 people and benefits from eight sourcing offices around the world and high-performance manufacturing operations across 15 sites in Europe, Morocco, the United States, Brazil, Australia, India, and Chile. It also has a global commercial presence through a dedicated network of 25 sales offices.

 

www.naturex.com

 

Your Naturex contacts:

 

Media

Antoine Dauby

Group Marketing Director

Tel: +334 90 23 96 89

a.dauby@naturex.com

 

Frédérique Carré

Media Relations Manager

Tel : +33 (0)4 90 23 96 89

f.carre@naturex.com

 

Investors

Carole Alexandre
Head of Investor Relations
Téléphone: +33 4 90 23 78 28

c.alexandre@naturex.com

 
of 221
BACK